Conavi Medical Corp. (TSXV:CNVI)
Canada · Delayed Price · Currency is CAD 0.1550
-0.0050 (-3.13%)
At close: Sep 21, 2026
Conavi Medical Earnings Call Transcripts
Fiscal Year 2024
-
A merger with Conavi is recommended after a thorough strategic review, offering Titan shareholders a 10% stake in a company with a unique, FDA-cleared imaging product and stronger growth prospects than a cash wind-down. All assets and IP will transfer to Conavi, and the board unanimously supports the deal.